EMBECTA CORP. Increase (Decrease) in Inventories
EMBECTA CORP. (EMBC) reported Increase (Decrease) in Inventories of $7.30 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-07
- EMBECTA CORP. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$10.10M, a 208.60% decline year-over-year.
- EMBECTA CORP. increase (decrease) in inventories for the quarter ending 2026-03-31 was $13.90M.
- EMBECTA CORP. increase (decrease) in inventories for the quarter ending 2025-12-31 was $3.50M, a 22.22% decline year-over-year.
- EMBECTA CORP. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$5.20M.
- EMBECTA CORP. increase (decrease) in inventories for fiscal 2025 was $6.10M, a 63.03% decline from fiscal 2024.
- EMBECTA CORP. increase (decrease) in inventories for fiscal 2024 was $16.50M, a 42.71% decline from fiscal 2023.
- EMBECTA CORP. increase (decrease) in inventories for fiscal 2023 was $28.80M, a 23.08% increase from fiscal 2022.
- EMBECTA CORP. increase (decrease) in inventories for fiscal 2022 was $23.40M, a 30.00% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $3.80M derived: sum of 2 quarters · filed 2026-08-07 | $7.30M 10-Q · filed 2026-08-07 | $2.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $13.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $17.40M 10-Q · filed 2026-05-05 | $12.20M derived: sum of 3 quarters · filed 2026-05-05 | $21.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.50M 10-Q · filed 2026-02-05 | -$1.70M derived: sum of 2 quarters · filed 2026-02-05 | $7.60M derived: sum of 3 quarters · filed 2026-08-07 | $5.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | -$5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $4.10M derived: sum of 2 quarters · filed 2026-08-07 | $1.60M derived: sum of 3 quarters · filed 2026-08-07 | $6.10M 10-K · filed 2025-11-25 |
| 2025-06-30 | $9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $6.80M derived: sum of 2 quarters · filed 2026-08-07 | $11.30M 10-Q · filed 2026-08-07 | -$5.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $2.00M 10-Q · filed 2026-05-05 | -$14.30M derived: sum of 3 quarters · filed 2026-05-05 | $20.50M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $4.50M 10-Q · filed 2026-02-05 | -$11.80M derived: sum of 2 quarters · filed 2026-02-05 | $23.00M derived: sum of 3 quarters · filed 2026-02-05 | $25.10M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | -$16.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $18.50M derived: sum of 2 quarters · filed 2025-11-25 | $20.60M derived: sum of 3 quarters · filed 2025-11-25 | $16.50M 10-K · filed 2025-11-25 |
| 2024-06-30 | $34.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $36.90M derived: sum of 2 quarters · filed 2025-08-08 | $32.80M 10-Q · filed 2025-08-08 | $19.10M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | -$2.00M 10-Q · filed 2025-05-09 | -$15.70M derived: sum of 3 quarters · filed 2025-11-25 | -$3.90M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | -$4.10M 10-Q · filed 2025-02-06 | -$17.80M derived: sum of 2 quarters · filed 2025-11-25 | -$6.00M derived: sum of 3 quarters · filed 2025-11-25 | $10.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | -$13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$1.90M derived: sum of 2 quarters · filed 2025-11-25 | $14.10M derived: sum of 3 quarters · filed 2025-11-25 | $28.80M 10-K · filed 2025-11-25 |
| 2023-06-30 | $11.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $27.80M derived: sum of 2 quarters · filed 2024-08-09 | $42.50M 10-Q · filed 2024-08-09 | $42.30M derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-03-31 | $16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $30.70M 10-Q · filed 2024-05-09 | $30.50M derived: sum of 3 quarters · filed 2024-12-11 | $44.10M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | $14.70M 10-Q · filed 2024-02-09 | $14.50M derived: sum of 2 quarters · filed 2024-12-11 | $28.10M derived: sum of 3 quarters · filed 2024-12-11 | $33.80M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $13.40M derived: sum of 2 quarters · filed 2024-12-11 | $19.10M derived: sum of 3 quarters · filed 2024-12-11 | $23.40M 10-K · filed 2024-12-11 |
| 2022-06-30 | $13.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $19.30M derived: sum of 2 quarters · filed 2023-08-08 | $23.60M 10-Q · filed 2023-08-08 | $24.90M derived: sum of 4 quarters · filed 2023-11-29 |
| 2022-03-31 | $5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $10.00M 10-Q · filed 2023-05-12 | $11.30M derived: sum of 3 quarters · filed 2023-11-29 | $18.90M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-12-31 | $4.30M 10-Q · filed 2023-02-14 | $5.60M derived: sum of 2 quarters · filed 2023-11-29 | $13.20M derived: sum of 3 quarters · filed 2023-11-29 | $11.90M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-09-30 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $8.90M derived: sum of 2 quarters · filed 2023-11-29 | $7.60M derived: sum of 3 quarters · filed 2023-11-29 | $18.00M 10-K · filed 2023-11-29 |
| 2021-06-30 | $7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $6.30M derived: sum of 2 quarters · filed 2022-08-15 | $16.70M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $9.10M 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $10.40M 10-Q · filed 2022-03-16 | |||
| 2020-09-30 | -$3.50M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |